Raymond Pfister

Raymond Pfister

Auto-generated profile, based on publicly available information

Raymond Pfister

CURCCCP Centre Universitaire Romand de Cardiologie Chirurgie Cardiaque Pédiatrique Universities of Lausanne and Geneva Rue du Bugnon 46, CH-1011 Lausanne Switzerland

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2020 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
PTPiergiorgio Tozzi
Piergiorgio Tozzi
ZGZiyad GUNGA
Ziyad GUNGA
LNLars Niclauss
Lars Niclauss
DDDominique Delay
Dominique Delay
ARAurelian Roumy
Aurelian Roumy
MKMatthias Kirsch
Matthias Kirsch
Current guidelines recommend prophylactic replacement of the ascending aorta at an aneurysmal diameter of >55 mm to prevent acute Type A aortic dissection (TAAD) in non-Marfan patients. Several publications have challenged this threshold, suggesting that surgery should be performed in smaller aneurysms to prevent this devastating disease. We reviewed our experience with measuring aortic size at the time of TAAD to validate the existing recommendation for prophylactic ascending aorta replacement. All patients who had been admitted for TAAD to our emergency department from 2014 to 2019 and underwent ascending aorta replacement were included. Marfan patients were excluded. The maximum diameter of the dissected aorta was measured preoperatively using CT scan. We estimated the aortic diameter at the time of dissection to be 7 mm smaller than the measured maximum diameter of the dissected aorta (modelled pre-dissection diameter). Overall, 102 patients were included. Of these, 67 were male (65.6%) and 35 were female (34.4%), and the cohort’s mean age was 65 ± 12.1 years. In addition, 66% were treated for arterial hypertension. The mean maximum modelled pre-dissection diameter was 39.6 ± 4.8 mm: 39.1 ± 5.1 mm in men and 40.7 ± 2.8 mm in women (P = 0.1). The cumulative 30-day mortality rate was 19.6% (20/102). TAAD occurred at a modelled aortic diameter below 45 mm in 87.7% of our patients. Therefore, the current aortic diameter threshold of 55 mm excludes ∼99% of patients with TAAD from prophylactic replacement of the ascending aorta. The maximum diameter of the ascending aorta warrants reappraisal and this parameter should be a distinct part of a personalized decision-making process that also takes into account age, gender and body surface area to establish the surgical indication for preventive aorta replacement aimed to improve the survival benefit of this procedure.

8 March 2019 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
RPRaymond Pfister
Raymond Pfister
YSYalda Sadeghi
Yalda Sadeghi
JOJavier Orrit
Javier Orrit
RPRené Prêtre
René Prêtre
Coronary artery aneurysms (CAA) are defined as localized coronary artery dilations more than 1.5 times the diameter of the adjacent segments [1]. Giant coronary aneurysms (GCAA) are unusual and aneurysms on the left side are even rarer. Mechanisms are unclear, but seem predominated by atherosclerosis. Until now, management of giant coronary aneurysm is still unclear. A 62-year-old man, presented a 4-month history of progressive chest pain aggravated by physical CAAs: 3 on the right coronary artery (RCA), including a giant one, and one on the intermediate branch. Intraoperatively, we found two proximal RCA CAAs of 2 cm each, a 6 cm distal RCA CAA partially thrombosed, and a 3 cm CAA on the intermediate branch. The two largest CAAs were resected and two saphenous graft bypasses were performed. Treatment options include medical treatment (antiaggregation, anticoagulation), percutaneous coronary angioplasty and surgery. Results of observational or conservative management in the few cases of GCAA described in literature, appear to have poor results. Surgery is a good option with low operative risk, especially in giant coronary aneurysms.

26 August 2020 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PMPatrick O Myers
Patrick O Myers
HDHitendu Dave
Hitendu Dave
OKOliver Kretschmar
Oliver Kretschmar
TSTornike Sologashvili
Tornike Sologashvili
RPRaymond Pfister
Raymond Pfister
RPRené Prêtre
René Prêtre
OBJECTIVES: Atrioventricular valve replacement in small children is associated with high morbidity and mortality. There are no prostheses available with a diameter ˂15 mm. This study reports our initial experience with a cylinder valve for mitral and tricuspid valve replacement in infants and small children.METHODS: Our cylinder valve was hand-made for patients requiring atrioventricuclar valve replacement with an annulus of <15 mm. A 12-mm Contegra valve was prepared and placed inside a 14-mm Gore-Tex tube graft and sutured on both extremities.RESULTS: Eight patients were included, with a median age of 6.9 months (range 1 day to 38 months). Four had mitral and 4 had tricuspid valve replacement. All implants were technically successful, with no significant regurgitation, no stenosis and no left ventricular outflow tract obstruction. There were 3 early deaths from low cardiac output, in patients with significant associated lesions (severe neonatal Ebstein’s, pulmonary artery-intact ventricular septum, biventricular conversion from Norwood stage 1). Two patients required early reintervention: 1 for balloon dilatation for stenosis and 1 for reoperation for paravalvular leak. During follow-up, 2 patients had mitral valve replacement with a 16-mm mechanical valve at 9 and 20 months from the cylinder valve implantation. The remaining 2 patients are alive and well 2 years and 2 months after the procedure.CONCLUSIONS: Cylinder valve replacement of atrioventricular valves was feasible without any technical issues. It was successful in getting out of a difficult situation and allows for somatic growth and implantation of a reasonably-sized mechanical prosthesis on the annulus.

10 November 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Open access
PDF file
LNLars Niclauss
Lars Niclauss
RPRaymond Pfister
Raymond Pfister
DDDominique Delay
Dominique Delay
PTPiergiorgio Tozzi
Piergiorgio Tozzi
MKMatthias Kirsch
Matthias Kirsch
RPRené Prêtre
René Prêtre
Background and aim of the study Guidelines indicate for type 5 myocardial infarction (MI) that postoperative troponin need not be exclusively ischemic but may also be caused by epicardial injury. Complexity arises from the introduction of high-sensitive troponin. This study attempts to contribute to the understanding of postoperative high-sensitive cardiac troponin T (hs-cTnT) increase. Methods The median enzyme increase of different cardiac operations was compared. Linear regression analyses were used to determine correlations between enzyme rise and independent parameters. Receiver-operating characteristics (ROC) served to evaluate the discriminatory power of enzyme rise in detecting ischemia and to determine possible thresholds. Results Among 400 patients, 2.8% had intervention-related ischemia analogous to type 5 MI definition. The median postoperative hs-cTnT/creatine kinase myocardial band (CK-MB) increase varied according to types of surgery, with highest increase after mitral valve and lowest after off-pump coronary surgery. After ruling out patients with preoperatively elevated hs-cTnT, regression analysis confirmed Maze procedure (p < .001), intra-pericardial defibrillation (p = .002), emergency intervention (p = .01), blood transfusions (p = .02), and cardiopulmonary bypass time (p = .03) as significant factors associated with hs-cTnT increase. In addition, CK-MB increase was associated with mortality (p = .002). ROC confirmed good discriminatory power for hs-cTnT and CK-MB with ischemia-indicating thresholds of 1705.5 ng/L (hs-cTnT) and 113 U/L (CK-MB) considering different types of operations. Conclusions The Influence of the type of surgery and intervention-related parameters on hs-cTnT increase was confirmed. Potential thresholds indicating perioperative ischemia appear to be significantly elevated for high sensitive markers.

2 November 2019 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
RPRaymond Pfister
Raymond Pfister
MKMatthias Kirsch
Matthias Kirsch
JNJulia Natterer
Julia Natterer
SBStefano Di Bernardo
Stefano Di Bernardo
RPRene Pretre
Rene Pretre

1 January 2002
Verified
Book Chapter
Closed access
ACAuteur Raymond Pfister Organisme Caritatif
Auteur Raymond Pfister Organisme Caritatif
HAHambourg
Hambourg
Les Assemblées de Dieu de France en Alsace1 1. Aperçu historique et points de repère Les Assemblées de Dieu de France (ci-après ADD) représentent depuis 1932 une expression classique du pentecôtisme et font partie d’une des grandes « familles » pentecôtistes du monde2. Douglas R. Scott (1900-1967), un prédicateur anglais originaire du Sussex et issu d’une communauté pentecôtiste « Elim », sera pendant près de quarante ans (1927-1967) une figure incontournable du pentecôtisme français3. Longtemp...